- QPOP Effective in Personalising Drug Combinations to Treat Relapsed Lymphoma – Mirage News
- New AI-driven Platform to Provide Treatment for Patients with Relapsed Lymphoma – 8world
- Condition of Patients with Relapsed Lymphoma Under Control with AI-tailored Drug Cocktail – Lianhe Zaobao
- AI Platform that Suggests Drug Cocktail for Patients with Relapsed Lymphoma to Undergo Clinical Trial Soon – The Straits Times
- QPOP Effective in Personalising Drug Combinations to Treat Relapsed Lymphoma – NUS News
- Tumor Analysis Platform Predicts Personalized Drug Combos for Non-Hodgkin Lymphoma Patients – Precision Oncology News
- A Lab for Bespoke Drug Treatments; where AI, Researchers Find Ways to Help Cancer Patients – CNA Insider
- NCIS & CSI Joint Study: Novel Oral Drug Combination Therapy Has Less Side Effects and Increased Efficacy in Controlling Advanced Breast Cancer – ZaoBao
- Drug combination could be less invasive treatment for breast cancer, study finds – The Straits Times
- Local Team Allocated $25 million to Start Research to Improve the Efficacy of Liver Cancer – ZaoBao
- S’pore Dedicates $25m to Liver Cancer Research to Find Targeted Treatments – The Straits Times
- Scientists Discover New Clues to Liver Cancer Progression – Medical Xpress
- Singapore Discovers New Clues to Liver Cancer Progression – BioSpectrum Asia
- Endothelial Cell Signaling May Drive Liver Cancer Progression – Technology Networks
- NUS Scientists Discover New Clues To Liver Cancer Progression – India Education Diary
- NUS scientists discover new clues to liver cancer progression – NUS News
- Drugs used to treat blood cancer could activate “sleeping” cancer-causing gene – NUS News
- NUS researchers identify novel pathways responsible for liver cancer – NUS News
